-transparent.png){kind=logo}
The prevalence of elevated antibody titers against Yersinia enterocolitica was studied in normal subjects, patients with a variety of nonthyroidal illnesses, and patients with thyroid disease. In contrast to the low prevalence of antibodies in controls (less than 8%), 48 of 67 patients (75%) with a variety of thyroid disorders had titers greater than 1:8. Antibodies were found in 24 of 36 patients with Graves' disease, five of six with autonomous adenoma, seven of seven with Hashimoto's thyroiditis, three of five with idiopathic primary hypothyroidism, four of 11 with nontoxic nodular goiter, and one of two with thyroid carcinoma. Antibodies to serotype 3 were the most prevalent, occurred in the highest titers, and were found particularly in patients with Graves' disease. These observations indicate that in spite of the infreqent occurrence of yersinia infection in the United States as compared with Scandinavia, patients with thyroid disorders have a higher prevalence of antibodies to Yersinia than normal subjects or patients with other disorders.
L Shenkman, and
E J Bottone
August 1978,
British medical journal,
L Shenkman, and
E J Bottone
January 1987,
Acta medica Austriaca,
L Shenkman, and
E J Bottone
August 1990,
Endocrinologia japonica,
L Shenkman, and
E J Bottone
July 2002,
Thyroid : official journal of the American Thyroid Association,
L Shenkman, and
E J Bottone
December 1974,
Lancet (London, England),
L Shenkman, and
E J Bottone
September 1988,
Acta endocrinologica,
L Shenkman, and
E J Bottone
April 1977,
Lancet (London, England),
L Shenkman, and
E J Bottone
June 1979,
Dermatologische Monatschrift,
L Shenkman, and
E J Bottone
July 1992,
The Journal of clinical endocrinology and metabolism,
L Shenkman, and
E J Bottone
January 1990,
Autoimmunity,
